Bank of America
TECX

Bank of America’s Tectonic Therapeutic TECX Stock Holding History

Bank of America’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$354K Buy
11,466
+2,241
+24% +$55.1K ﹤0.01% 5074
2025
Q4 		$192K Buy
9,225
+2,860
+45% +$53.1K ﹤0.01% 5365
2025
Q3 		$99.9K Sell
6,365
-557
-8% -$11.5K ﹤0.01% 6596
2025
Q2 		$138K Sell
6,922
-58,779
-89% -$1.19M ﹤0.01% 6355
2025
Q1 		$1.16M Buy
65,701
+65,572
+50,831% +$2.14M ﹤0.01% 5117
2024
Q4 		$5.96K Sell
129
-33
-20% -$1.4K ﹤0.01% 7073
2024
Q3 		$4.91K Sell
162
-74
-31% -$1.35K ﹤0.01% 7013
2024
Q2 		$3.89K Buy
+236
New +$3.78K ﹤0.01% 7057
2024
Q1 		– Sell
-3
Closed -$48 – 7640
2023
Q4 		$40 Buy
+3
New +$52 ﹤0.01% 7543
2023
Q3 		– Hold
0
– – – 7682
2023
Q2 		– Sell
-69
Closed -$780 – 7644
2023
Q1 		$831 Buy
69
+61
+763% +$849 ﹤0.01% 7325
2022
Q4 		$72 Buy
8
+2
+33% +$18 ﹤0.01% 7736
2022
Q3 		$0 Sell
6
-312
-98% -$3.46K ﹤0.01% 8256
2022
Q2 		$4K Sell
318
-729
-70% -$8.59K ﹤0.01% 7663
2022
Q1 		$17K Sell
1,047
-939
-47% -$19.4K ﹤0.01% 7585
2021
Q4 		$92K Sell
1,986
-680
-26% -$39.1K ﹤0.01% 6923
2021
Q3 		$179K Buy
2,666
+847
+47% +$69.5K ﹤0.01% 6376
2021
Q2 		$194K Sell
1,819
-1,102
-38% -$131K ﹤0.01% 6121
2021
Q1 		$445K Buy
2,921
+543
+23% +$88.3K ﹤0.01% 5467
2020
Q4 		$398K Buy
2,378
+928
+64% +$165K ﹤0.01% 5156
2020
Q3 		$227K Buy
1,450
+178
+14% +$35.9K ﹤0.01% 5224
2020
Q2 		$267K Sell
1,272
-765
-38% -$158K ﹤0.01% 5057
2020
Q1 		$380K Buy
2,037
+466
+30% +$110K ﹤0.01% 4705
2019
Q4 		$379K Sell
1,571
-1,072
-41% -$207K ﹤0.01% 5207
2019
Q3 		$448K Buy
2,643
+2,135
+420% +$483K ﹤0.01% 5159
2019
Q2 		$99K Buy
508
+53
+12% +$11.4K ﹤0.01% 6023
2019
Q1 		$120K Buy
455
+59
+15% +$10.8K ﹤0.01% 5785
2018
Q4 		$79K Buy
396
+297
+300% +$90.5K ﹤0.01% 6030
2018
Q3 		$61K Buy
+99
New +$43.9K ﹤0.01% 6122

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Bank of America's TECX Position: Q1 2026 in Review

Bank of America increased its Tectonic Therapeutic (TECX) stake by 24% in Q1 2026, buying an estimated $55.1K and bringing the position to 11,466 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #5074.

Bank of America first reported a position in TECX in Q3 2018 and has held it in 28 quarters since. The position peaked at $1.16M in Q1 2025. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Bank of America held 11,466 shares of Tectonic Therapeutic worth $354K as of Q1 2026.
  • Bank of America bought 2,241 Tectonic Therapeutic shares in Q1 2026, an estimated $55.1K.
  • Tectonic Therapeutic made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5074 holding.
  • Bank of America first reported a position in Tectonic Therapeutic in Q3 2018 and has held it in 28 quarters since.
  • Bank of America's Tectonic Therapeutic position peaked at $1.16M in Q1 2025.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.